Expression of Tenascin in Human Cervical Cancer—Association of Tenascin Expression with Clinicopathological Parameters

This publication has 26 references indexed in Scilit:

• CD44 is an independent prognostic factor in early-stage cervical cancer
  International Journal of Cancer, 1997
• Inhibition of Cell Attachment, Invasion and Metastasis of Human Carcinoma Cells by Anti‐integrin β₁ Subunit Antibody
  Japanese Journal of Cancer Research, 1992
• Tenascin variants: differential binding to fibronectin and distinct distribution in cell cultures and tissues.
  Cell Regulation, 1991
• Lokale Immunreaktionen bei CIN und Zervixkarzinom - Eine histologische und immunhistochemische Studie*
  Geburtshilfe und Frauenheilkunde, 1991
• Tenascin: An Extracellular Matrix Protein Prominent in Specialized Embryonic Tissues and Tumors
  Annual Review of Cell Biology, 1989
• Induction of tenascin in healing wounds.
  The Journal of cell biology, 1988
• Tenascin is a stromal marker for epithelial malignancy in the mammary gland.
  Proceedings of the National Academy of Sciences, 1987
• Epithelial-mesenchymal interactions in the developing kidney lead to expression of tenascin in the mesenchyme.
  The Journal of cell biology, 1987
• Tenascin: an extracellular matrix protein involved in tissue interactions during fetal development and oncogenesis
  Cell, 1986
• Chick myotendinous antigen. I. A monoclonal antibody as a marker for tendon and muscle morphogenesis.
  The Journal of cell biology, 1984